(NEW YORK)UBS Investment Research downgraded shares of drug developer GlaxoSmithKline on Friday but still considers it one of the most likely in the pharma sector to come through with blockb...READ MORE

(TRENTON, N.J.)Pfizer Inc., the world's largest drugmaker, said Friday it has launched a new biotechnology research unit focused on developing stem cell-based treatments for a wide range of condi...READ MORE

(NEW ORLEANS)The controversial diabetes pill Avandia failed to significantly slow plaque buildup in heart arteries compared with an older drug, though there were some hopeful signs in a new stu...READ MORE

(NEW YORK)GlaxoSmithKline said Wednesday it is moving ahead with its plan to purchase all shares of drug developer Genelabs Technologies Inc. for $57 million. London-based GlaxoSmithKline, t...READ MORE

(LONDON)British drug maker GlaxoSmithKline PLC said Tuesday it is planning to close one of its English plants, which employs 620 people, by 2013 because the majority of drugs made at the p...READ MORE

(WASHINGTON)Perhaps no sector has more to gain under the Obama administration than the nation's fledgling stem cell companies, which have long bemoaned a Bush policy that limits funding to emb...READ MORE

(LONDON)British drug maker GlaxoSmithKline PLC said Tuesday it plans to close one of its English plants, which employs 620, by 2013 because the majority of drugs made there are losing thei...READ MORE